Abstract
Interning at the marketing team of Emcure Pharmaceuticals Ltd. Pune, India, in June 2022, I researched on changing trends in the global pharma sector due to the ongoing pandemic. While individual pharma rms navigated several of these amendments, some alterations were steered industry-wide and exterior aspects, including public and government involvement, also inuenced the shaping of the new normal healing situation, which are discussed here. Further, this white paper analyzes the current and future trends of the Indian pharmaceutical world including - the market value of the sector, pharma exports and imports from which nations, the advantages faced by this industry and the investments in research and development within this sector as a percentage of pharmaceutical sales. This report talks about the establishment of Cipla; the brand's core values; its robust progress in India as well as in its prime international markets of North America and South Africa in terms of - branded prescriptions, trade generics and consumer wellness, digital leap and revenue enhancement. It concludes with information on the pandemic-centric new operating models leapfrogging the pharma world, the fresh technological skills adopted by the industry to enhance future growth and the rethinking of strategies for progress.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
